MJS,Good summary of the situation. I too have been a long term holder. I'd like to see the buyback ramped up at these discounts before I was convinced mgt. have changed their stripes.
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling
